January 8, 2018
Amryt to distribute Lojuxta with RCC Pharma in Switzerland
Amryt, a biopharmaceutical company focused on rare and orphan diseases, has signed an agreement for distributing its Lojuxta through RCC…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
January 8, 2018
Sanofi and Regeneron to boost investment for two development programs
Sanofi and Regeneron Pharmaceuticals said they will accelerate and expand investment for the clinical development of the PD-1 (programmed cell…
January 8, 2018
Horizon Pharma’s MEDI4945 has potential for subcutaneous dosing and reduced immunogenicity?
Horizon Pharma has licensed the global rights to MEDI4945, a pre-clinical, genetically engineered uricase derivative combined with site-specific PEGylation, from…
January 8, 2018
Good news for Matinas BioPharma’s treatment for Chronic Refractory Mucocutaneous Candidiasis
Matinas BioPharma Holdings said Monday that the National Institutes of Health (NIH) has revealed positive data from a third patient…
January 8, 2018
Faller with three prototypes in line with the theme of smart packaging at Pharmapack 2018
Faller, a German-based player in packaging in the pharma industry is presenting three prototypes in line with the theme of…
January 8, 2018
Calgene Corp buys Impact Biomedicines for $2,3 billion
Celgene Corporation and Impact Biomedicines have agreed for Celgene to acquire Impact Biomedicines, which is developing fedratinib for myelofibrosis and…
January 8, 2018
Novo Nordisk in Ablynx €2.6 Billion buy
Novo Nordisk on Monday confirmed proposing on December 22, 2017 to acquire Ablynx for €28.00 per share in cash and…
January 8, 2018
Targovax welcomes new business leader
Targovax ASA, a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announced on Monday that Michael…
January 5, 2018
Pharmapack Europe 2018 to showcase evolution and revolution in packaging and drug delivery
Pharmapack Europe 2018 will have a programme for Europe’s dedicated pharmaceutical packaging and drug delivery conference and exhibition taking place…
January 5, 2018
Takeda buys TiGenix
Belgian-based biopharmaceutical company TiGenix NV on Friday confirmed that Takeda Pharmaceutical Company has announced its intention buy TiGenix.